Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE2

Conditions

Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tanta Unuversity, Tanta, Egypt
Contact: Study coordinator (Eman I Elberri, PhD) · mbahaa@horus.edu.eg · 0201003592593
Mostafa M Bahaa, PhD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Pancreatitis, Chronic · Pancreatitis, Acute · Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Rochester, United States · Pittsburgh, United States

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Nashville, United States

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Chronic Kidney Disease (Stages 4 and 5) · Kidney Disease · Type 2 Diabetes

Abroad (travel likely)Recruiting

Phoenix, United States

Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes

Type 1 Diabetes Mellitus

Abroad (travel likely)Recruiting

Prague, Czechia